Both P110, a peptide inhibitor that selectively suppressed Drp1 hyperactivation12, and HV-3, which specifically blocked mtHtt/valosin-containing protein interaction13, rescued mitochondrial damage, reduced neuronal cell death, and attenuated behavioral deficits in HD transgenic mice13,14. The gene discussed is DNM1L; the disease is Huntington disease.